Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases

Journal of Clinical Investigation

Volumn 119, Issue 4, 2009, Pages 924-935

  Uetani, Noriko ^a   Bertozzi, Kristen ^a   Chagnon, Melanie J ^a   Hendriks, Wiljan ^b   Tremblay, Michel L ^a   Bouchard, Maxime ^a  

^a MCGILL UNIVERSITY   (Canada)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; PROTEIN RET; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE PTPRF; PROTEIN TYROSINE PHOSPHATASE PTPRS; UNCLASSIFIED DRUG; PTPRF PROTEIN, MOUSE; PTPRS PROTEIN, MOUSE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; RET PROTEIN, MOUSE;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER; BLADDER WALL; CELL CULTURE; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; CRANIOFACIAL MORPHOLOGY; DISEASE SEVERITY; EMBRYO; EXENCEPHALY; HUMAN; HUMAN CELL; HYDROURETER; MICROGNATHIA; MORPHOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; URETER; URETER BLADDER CONNECTION; URETEROCELE; UROGENITAL TRACT MALFORMATION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CONGENITAL MALFORMATION; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MOUSE MUTANT; MULTIPLE MALFORMATION SYNDROME; PHOSPHORYLATION; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT;

ABNORMALITIES, MULTIPLE; ANIMALS; APOPTOSIS; CRANIOFACIAL ABNORMALITIES; FEMALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PREGNANCY; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; URETER; URINARY BLADDER;

EID: 65249115238     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37196     Document Type: Article

References (47)

1. Daneman, A., and Alton, D.J. 1991. Radiographic manifestations of renal anomalies. Radiol. Clin. North Am. 29:351-363.
2. Mackie, G.G., and Stephens, F.D. 1975. Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice. J. Urol. 114:274-280.
3. Miyazaki, Y., and Ichikawa, I. 2003. Ontogeny of congenital anomalies of the kidney and urinary tract, CAKUT. Pediatr. Int. 45:598-604.
4. Thomas, J.C., DeMarco, R.T., and Pope, J.C., 4th. 2005. Molecular biology of ureteral bud and trigonal development. Curr. Urol. Rep. 6:146-151.
5. Murawski, I.J., Myburgh, D.B., Favor, J., and Gupta, I.R. 2007. Vesico-ureteric reflux and urinary tract development in the Pax2 1Neu+/- mouse. Am. J. Physiol. Renal Physiol. 293:F1736-F1745.
6. Grieshammer, U., et al. 2004. SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev. Cell. 6:709-717.
7. Kume, T., Deng, K., and Hogan, B.L. 2000. Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development. 127:1387-1395.
8. Miyazaki, Y., Oshima, K., Fogo, A., Hogan, B.L., and Ichikawa, I. 2000. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J. Clin. Invest. 105:863-873.
9. Basson, M.A., et al. 2005. Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev. Cell. 8:229-239.
10. Batourina, E., et al. 2005. Apoptosis induced by vitamin A signaling is crucial for connecting the ureters to the bladder. Nat. Genet. 37:1082-1089.
11. Costantini, F., and Shakya, R. 2006. GDNF/Ret signaling and the development of the kidney. Bioessays. 28:117-127.
12. Batourina, E., et al. 2002. Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. Nat. Genet. 32:109-115.
13. Asai, N., et al. 2006. RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease. Pathol. Int. 56:164-172.
14. Jijiwa, M., et al. 2004. A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. Mol. Cell. Biol. 24:8026-8036.
15. Jain, S., Encinas, M., Johnson, E.M., Jr., and Milbrandt, J. 2006. Critical and distinct roles for key RET tyrosine docking sites in renal development. Genes Dev. 20:321-333.
16. Wong, A., et al. 2005. Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform. Mol. Cell. Biol. 25:9661-9673.
17. Pulido, R., Krueger, N.X., Serra-Pages, C., Saito, H., and Streuli, M. 1995. Molecular characterization of the human transmembrane protein-tyrosine phosphatase delta. Evidence for tissue-specific expression of alternative human transmembrane protein-tyrosine phosphatase delta isoforms. J. Biol. Chem. 270:6722-6728.
18. Uetani, N., Chagnon, M.J., Kennedy, T.E., Iwakura, Y., and Tremblay, M.L. 2006. Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J. Neurosci. 26:5872-5880.
19. Elchebly, M., et al. 1999. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma. Nat. Genet. 21:330-333.
20. Thompson, K.M., et al. 2003. Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension. Mol. Cell. Neurosci. 23:681-692.
21. Sapieha, P.S., et al. 2005. Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Mol. Cell. Neurosci. 28:625-635.
22. Chagnon, M.J., et al. 2006. Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma. Can. J. Physiol. Pharmacol. 84:755-763.
23. Schaapveld, R.Q., et al. 1997. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Dev. Biol. 188:134-146.
24. Van Lieshout, E.M., Van der Heijden, I., Hendriks, W.J., and Van der Zee, C.E. 2001. A decrease in size and number of basal forebrain cholinergic neurons is paralleled by diminished hippocampal cholinergic innervation in mice lacking leukocyte common antigen-related protein tyrosine phosphatase activity. Neuroscience. 102:833-841.
25. Dunah, A.W., et al. 2005. LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses. Nat. Neurosci. 8:458-467.
26. Bernabeu, R., et al. 2006. Downregulation of the LAR protein tyrosine phosphatase receptor is associated with increased dentate gyrus neurogenesis and an increased number of granule cell layer neurons. Mol. Cell. Neurosci. 31:723-738.
27. Qiao, S., et al. 2001. Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins. J. Biol. Chem. 276:9460-9467.
28. Jin, Z., and El-Deiry, W.S. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4:139-163.
29. Airaksinen, M.S., and Saarma, M. 2002. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394.
30. Putzer, B.M., and Drosten, M. 2004. The RET proto-oncogene: a potential target for molecular cancer therapy. Trends Mol. Med. 10:351-357.
31. MacKeigan, J.P., Murphy, L.O., and Blenis, J. 2005. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat. Cell Biol. 7:591-600.
32. Weng, L.P., Yuan, J., and Yu, Q. 1998. Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis. Curr. Biol. 8:247-256.
33. Tisi, M.A., Xie, Y., Yeo, T.T., and Longo, F.M. 2000. Downregulation of LAR tyrosine phosphatase prevents apoptosis and augments NGF-induced neurite outgrowth. J. Neurobiol. 42:477-486.
34. Weng, L.P., Wang, X., and Yu, Q. 1999. Transmembrane tyrosine phosphatase LAR induces apoptosis by dephosphorylating and destabilizing p130Cas. Genes Cells. 4:185-196.
35. Wang, W.J., et al. 2007. The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR. Mol. Cell. 27:701-716.
36. Lorber, B., Hendriks, W.J., Van der Zee, C.E., Berry, M., and Logan, A. 2005. Effects of LAR and PTPBL phosphatase deficiency on adult mouse retinal cells activated by lens injury. Eur. J. Neurosci. 21:2375-2383.
37. Schaapveld , R.Q., et al. 1998. Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse. Mech. Dev. 77:59-62.
38. Uetani, N., et al. 2000. Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. EMBO J. 19:2775-2785.
39. Penaloza, C., Lin, L., Lockshin, R.A., and Zakeri, Z. 2006. Cell death in development: shaping the embryo. Histochem. Cell Biol. 126:149-158.
40. Kulesa, P., Ellies, D.L., and Trainor, P.A. 2004. Comparative analysis of neural crest cell death, migration, and function during vertebrate embryogenesis. Dev. Dyn. 229:14-29.
41. Dudas, M., Li, W.Y., Kim, J., Yang, A., and Kaartinen, V. 2007. Palatal fusion - where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem. 109:1-14.
42. Hahn, P., et al. 2005. Persistent fetal ocular vasculature in mice deficient in bax and bak. Arch. Ophthalmol. 123:797-802.
43. Amiel, J., et al. 2008. Hirschsprung disease, associated syndromes and genetics: a review. J. Med. Genet. 45:1-14.
44. Kobrynski, L.J., and Sullivan, K.E. 2007. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 370:1443-1452.
45. Henrique, D., et al. 1995. Expression of a Delta homologue in prospective neurons in the chick. Nature. 375:787-790.
46. Mizuno, K., et al. 1993. MPTP delta, a putative murine homolog of HPTP delta, is expressed in specialized regions of the brain and in the B-cell lineage. Mol. Cell. Biol. 13:5513-5523.
47. Pachnis, V., Mankoo, B., and Costantini, F. 1993. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development. 119:1005-1017.